Moderna's Spikevax vaccine is the first to receive full approval for use in children aged 6 months to 11 years with a high-risk health issue.

With an extremely active kid, having a first aid kit just makes sense, and doctors agree. "It makes you feel a little less ...

The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.